Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

BUY
$35.55 - $43.57 $2.01 Million - $2.46 Million
56,522 Added 39.37%
200,077 $8.69 Million
Q3 2023

Oct 24, 2023

BUY
$39.13 - $47.24 $1,291 - $1,558
33 Added 0.02%
143,555 $5.81 Million
Q2 2023

Jul 25, 2023

BUY
$43.93 - $46.76 $25,786 - $27,448
587 Added 0.41%
143,522 $6.46 Million
Q1 2023

Apr 14, 2023

BUY
$45.29 - $50.76 $2.33 Million - $2.61 Million
51,466 Added 56.27%
142,935 $6.57 Million
Q4 2022

Feb 08, 2023

BUY
$41.91 - $50.48 $1.65 Million - $1.98 Million
39,318 Added 75.39%
91,469 $4.56 Million
Q3 2022

Oct 25, 2022

SELL
$40.9 - $50.42 $270,308 - $333,225
-6,609 Reduced 11.25%
52,151 $2.15 Million
Q2 2022

Aug 12, 2022

BUY
$42.98 - $49.77 $451,633 - $522,983
10,508 Added 21.78%
58,760 $2.77 Million
Q1 2022

May 11, 2022

BUY
$42.23 - $54.3 $275,212 - $353,873
6,517 Added 15.62%
48,252 $2.36 Million
Q4 2021

Feb 08, 2022

BUY
$50.62 - $56.47 $648,847 - $723,832
12,818 Added 44.33%
41,735 $2.32 Million
Q3 2021

Nov 02, 2021

SELL
$46.55 - $56.83 $33,050 - $40,349
-710 Reduced 2.4%
28,917 $1.5 Million
Q2 2021

Aug 11, 2021

SELL
$46.28 - $52.75 $3.86 Million - $4.4 Million
-83,465 Reduced 73.8%
29,627 $1.43 Million
Q1 2021

May 14, 2021

BUY
$46.25 - $56.02 $1.27 Million - $1.54 Million
27,482 Added 32.1%
113,092 $5.48 Million
Q4 2020

Feb 12, 2021

BUY
$46.09 - $54.74 $3.95 Million - $4.69 Million
85,610 New
85,610 $4.47 Million
Q3 2020

Nov 04, 2020

SELL
$42.51 - $52.42 $3.59 Million - $4.43 Million
-84,442 Closed
0 $0
Q2 2020

Jul 28, 2020

SELL
$39.49 - $44.36 $378,669 - $425,368
-9,589 Reduced 10.2%
84,442 $3.64 Million
Q1 2020

Apr 21, 2020

SELL
$33.17 - $41.6 $2.9 Million - $3.63 Million
-87,297 Reduced 48.14%
94,031 $3.8 Million
Q4 2019

Feb 12, 2020

BUY
$25.41 - $43.1 $4.61 Million - $7.82 Million
181,328 New
181,328 $6.19 Million

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.5B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.